share_log

Applied Uv | 424B5: Prospectus

SEC announcement ·  Mar 29 17:13
Summary by Moomoo AI
Applied UV, Inc. (Applied UV), a provider of disinfection technology solutions, has announced the offering of 538,000 shares of its common stock at a price of $1.60 per share. The offering is directly targeted at certain institutional investors and is accompanied by the issuance of pre-funded warrants to purchase up to 1,188,875 shares of common stock. These pre-funded warrants are being offered to purchasers whose acquisition of common stock would otherwise result in ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of Applied UV's outstanding common stock post-offering. The exercise price for each pre-funded warrant is $0.0001 per share. Additionally, Applied UV is offering 518,065 private placement warrants in a concurrent private placement, exercisable for one share of common...Show More
Applied UV, Inc. (Applied UV), a provider of disinfection technology solutions, has announced the offering of 538,000 shares of its common stock at a price of $1.60 per share. The offering is directly targeted at certain institutional investors and is accompanied by the issuance of pre-funded warrants to purchase up to 1,188,875 shares of common stock. These pre-funded warrants are being offered to purchasers whose acquisition of common stock would otherwise result in ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of Applied UV's outstanding common stock post-offering. The exercise price for each pre-funded warrant is $0.0001 per share. Additionally, Applied UV is offering 518,065 private placement warrants in a concurrent private placement, exercisable for one share of common stock each, with an initial exercise price of $16.00 per share. The private placement warrants and the shares of common stock issuable upon their exercise are not registered under the Securities Act of 1933 and are being offered pursuant to an exemption from registration requirements. The offering price was determined through negotiations between Applied UV, Aegis Capital Corp. (the Placement Agent), and the investors. The offering is expected to close on March 27, 2024, subject to customary closing conditions.

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more